logo

IKS Health Share Price Jumps 6.57% After Q2 FY26 Profit Jumps 60% YoY

By Shishta Dutta | Published at: Oct 31, 2025 10:47 AM IST

IKS Health Share Price Jumps 6.57% After Q2 FY26 Profit Jumps 60% YoY
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Mumbai, October 31: IKS Health’s share price is witnessing a significant rally today, after the company reported a strong financial result for the quarter ending September 30, 2025. It reported a 60% year-on-year rise in profit after tax (PAT) and a 22% jump in revenue. As of 10:00 AM, IKS Health’s stock price was up by 6.57%, or 102.90 points and was trading at ₹1,670. Until now, the IKS Health shares have traded within a range of ₹1,679.60 and ₹1,550.50. The traded volume stood at 12.19 lakh shares, with the company’s market cap at ₹26,901 crore. The IKS Health stock has its 52-week high at ₹2,189 and its 52-week low at ₹1,236.80.

Inventurus Knowledge Solutions Limited (NSE: IKS | BSE: 544309) is an Indian company that provides technology-backed healthcare solutions. The company was established in 2006 and is headquartered in Mumbai, Maharashtra.

Shares Jump After Strong Q2 FY26 Financial Performance

The rise in share price followed the company’s strong Q2 FY26 financial performance. For Q2 FY26, the company’s revenue was ₹7,811 million, a 22% YoY rise and 6% QoQ growth from ₹7,401 million in Q1 FY26 and ₹6,428 million in Q2 FY25. EBITDA was at ₹2,718 million, up 43% YoY and 14% QoQ. PAT increased to ₹1,807 million, a rise of 60% YoY and 19% QoQ. The company’s EBITDA margin was 35% and PAT margin 23%.

The company has expanded its engagement with Advent Health to include new value-based care offerings. It also established a new partnership with Revere Health. The partnership is aimed at modernising their billing, collections, and denial prevention processes. Furthermore, The Jackson Clinic has signed an agreement with the company to manage its revenue cycle and clinical support operations. Finally, a leading cardiology group has expanded its existing contract. Under the contract, IKS Health will enhance its revenue performance and reduce inefficiencies.

The strong financial performance of IKS Health is driving positive investor sentiment today. With a 60% increase in net profit, investors are hopeful for the company’s long-term growth. The stock is trading at high volumes and is expected to end the week in the green.

REF: https://nsearchives.nseindia.com/corporate/ShubhamIKS_30102025212715_20251030PressRelease.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy